Literature DB >> 9013299

The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization.

B C Tarlatzis1, G Grimbizis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9013299      PMCID： PMC3454715          DOI： 10.1007/bf02765740

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN： 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  21 in total

1.  Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation.

Authors:  C M Howles; M C Macnamee; R G Edwards; R Goswamy; P C Steptoe
Journal:  Lancet       Date:  1986-08-30       Impact factor: 79.321

Review 2.  Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage.

Authors:  A H Balen; S L Tan; H S Jacobs
Journal:  Br J Obstet Gynaecol       Date:  1993-12

Review 3.  Assisted reproduction techniques in polycystic ovarian syndrome.

Authors:  B C Tarlatzis; G Grimbizis
Journal:  Ann N Y Acad Sci       Date:  1993-05-28       Impact factor: 5.691

4.  Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease.

Authors:  A Lanzone; A M Fulghesu; M A Spina; R Apa; E Menini; A Caruso; S Mancuso
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

5.  Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome.

Authors:  K Takahashi; Y Eda; A Abu-Musa; S Okada; K Yoshino; M Kitao
Journal:  Hum Reprod       Date:  1994-07       Impact factor: 6.918

6.  In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome.

Authors:  R Homburg; D Berkowitz; T Levy; D Feldberg; J Ashkenazi; Z Ben-Rafael
Journal:  Fertil Steril       Date:  1993-11       Impact factor: 7.329

7.  Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage.

Authors:  H Watson; D S Kiddy; D Hamilton-Fairley; M J Scanlon; C Barnard; W P Collins; R C Bonney; S Franks
Journal:  Hum Reprod       Date:  1993-06       Impact factor: 6.918

8.  Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase.

Authors:  J D Stanger; J L Yovich
Journal:  Br J Obstet Gynaecol       Date:  1985-04

9.  Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.

Authors:  R Homburg; N A Armar; A Eshel; J Adams; H S Jacobs
Journal:  BMJ       Date:  1988-10-22

10.  The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.

Authors:  B C Tarlatzis; G Grimbizis; F Pournaropoulos; J Bontis; S Lagos; E Spanos; S Mantalenakis
Journal:  Hum Reprod       Date:  1995-10       Impact factor: 6.918
View more
  4 in total

1.  Patients with polycystic ovary syndrome have successful embryo arrest.

Authors:  Baoli Yin; Haoying Hao; Duo Wei; Xiaobing Song; Juanke Xie; Cuilian Zhang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 2.  Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.

Authors:  Jie Qiao; Huai L Feng
Journal:  Hum Reprod Update       Date:  2010-07-16       Impact factor: 15.610

Review 3.  Polycystic Ovary Syndrome: Implication for Drug Metabolism on Assisted Reproductive Techniques-A Literature Review.

Authors:  Enrique Reyes-Muñoz; Thozhukat Sathyapalan; Paola Rossetti; Mohsin Shah; Min Long; Massimo Buscema; Gaetano Valenti; Valentina Lucia La Rosa; Stefano Cianci; Salvatore Giovanni Vitale
Journal:  Adv Ther       Date:  2018-10-11       Impact factor: 3.845

4.  Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent in vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: Comparing With Short Protocol.

Authors:  Chen Chen; Sha Yu; Weina Yu; Zhiguang Yan; Wei Jin; Jiqiang Si; Menghui Li; Renfei Cai; Dongying Li; Li Wang; Qiuju Chen; Yanping Kuang; Qifeng Lyu; Hui Long
Journal:  Front Physiol       Date:  2022-02-11       Impact factor: 4.566
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.